Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer and the Immune System: The History and Background of Immunotherapy
Maura Abbott, Yelena Ustoyev
Seminars in Oncology Nursing (2019) Vol. 35, Iss. 5, pp. 150923-150923
Closed Access | Times Cited: 385

Showing 1-25 of 385 citing articles:

CAR T-Cell-Based gene therapy for cancers: new perspectives, challenges, and clinical developments
Manasi P. Jogalekar, Ramya Lakshmi Rajendran, Fatima Khan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 132
CAR-NK cells for cancer immunotherapy: from bench to bedside
Leisheng Zhang, Meng Yuan, Xiaoming Feng, et al.
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 128
The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy
Wenxiao Jiang, Shuya Pan, Xin Chen, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 120
Gel/hydrogel‐based in situ biomaterial platforms for cancer postoperative treatment and recovery
Yuzhao Feng, Zhan Zhang, Wei Tang, et al.
Exploration (2023) Vol. 3, Iss. 5
Open Access | Times Cited: 86
Aptamers as an approach to targeted cancer therapy
Fatemeh Mahmoudian, Azin Ahmari, Shiva Shabani, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 32
Pulmonary toxicity of immune checkpoint immunotherapy
Mohammad I. Ghanbar, Karthik Suresh
Journal of Clinical Investigation (2024) Vol. 134, Iss. 2
Open Access | Times Cited: 21
Recent advances in the metal/organic hybrid nanomaterials for cancer theranostics
Zhaoyi Ye, Ying Bao, Zefeng Chen, et al.
Coordination Chemistry Reviews (2024) Vol. 504, pp. 215654-215654
Closed Access | Times Cited: 18
The APE1/REF-1 and the hallmarks of cancer
Priscyanne Barreto Siqueira, Mariana Moreno de Sousa Rodrigues, Ísis Salviano Soares de Amorim, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 17
Emergence and impact of theranostic‐nanoformulation of triple therapeutics for combination cancer therapy
Amit Kumar Rajora, Eknath D. Ahire, Manju A. K. Rajora, et al.
Smart Medicine (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 16
Radiotherapy and the immune system: More than just immune suppression
Michael Rückert, Ann-Sophie Flohr, Markus Hecht, et al.
Stem Cells (2021) Vol. 39, Iss. 9, pp. 1155-1165
Open Access | Times Cited: 87
Technological advances in cancer immunity: from immunogenomics to single-cell analysis and artificial intelligence
Ying Xu, Guan-Hua Su, Ding Ma, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 86
The spontaneous remission of cancer: Current insights and therapeutic significance
Gudapureddy Radha, Manu Lopus
Translational Oncology (2021) Vol. 14, Iss. 9, pp. 101166-101166
Open Access | Times Cited: 67
Small molecule-based immunomodulators for cancer therapy
Yinrong Wu, Zichao Yang, Kui Cheng, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 12, pp. 4287-4308
Open Access | Times Cited: 67
The Impact of the Microbiome on Resistance to Cancer Treatment with Chemotherapeutic Agents and Immunotherapy
Aneta Sevcikova, Nikola Izoldova, Viola Stevurkova, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 488-488
Open Access | Times Cited: 63
Single cell RNA-seq reveals the CCL5/SDC1 receptor-ligand interaction between T cells and tumor cells in pancreatic cancer
Kai Chen, Shaobin Wang, Yuting Hou, et al.
Cancer Letters (2022) Vol. 545, pp. 215834-215834
Closed Access | Times Cited: 61
Tumor-Associated Extracellular Matrix: How to Be a Potential Aide to Anti-tumor Immunotherapy?
Yingying He, Tao Liu, Shuang Dai, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 56
Applications of Focused Ultrasound for the Treatment of Glioblastoma: A New Frontier
Andrew M. Hersh, Meghana Bhimreddy, Carly Weber-Levine, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4920-4920
Open Access | Times Cited: 46
Mast Cell–Tumor Interactions: Molecular Mechanisms of Recruitment, Intratumoral Communication and Potential Therapeutic Targets for Tumor Growth
Deisy Segura-Villalobos, Itzel G. Ramírez-Moreno, Magnolia Martínez-Aguilar, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 349-349
Open Access | Times Cited: 44
Latest research progress on anticancer effect of baicalin and its aglycone baicalein
Lin Wang, Ting Feng, Zhilian Su, et al.
Archives of Pharmacal Research (2022) Vol. 45, Iss. 8, pp. 535-557
Closed Access | Times Cited: 43
The future of cancer immunotherapy: DNA vaccines leading the way
Aanshi J. Pandya, Yesha Shah, Nirjari Kothari, et al.
Medical Oncology (2023) Vol. 40, Iss. 7
Open Access | Times Cited: 40
Remodeled tumor immune microenvironment (TIME) parade via natural killer cells reprogramming in breast cancer
Mona M. Elanany, Dina Mostafa, Nadia Μ. Hamdy
Life Sciences (2023) Vol. 330, pp. 121997-121997
Closed Access | Times Cited: 32
Photothermal-triggered dendrimer nanovaccines boost systemic antitumor immunity
Siyan Shen, Yue Gao, Zhijun Ouyang, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 171-183
Closed Access | Times Cited: 28
CircRNAs in tumor immunity and immunotherapy: Perspectives from innate and adaptive immunity
Lulu Yu, Qi Xiao, Bing Yu, et al.
Cancer Letters (2023) Vol. 564, pp. 216219-216219
Open Access | Times Cited: 23
The role of LncRNAs in tumor immunotherapy
Xuan Pan, Chenchen Li, Jifeng Feng
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 22
Role of Defensins in Tumor Biology
Lowie Adyns, Paul Proost, Sofie Struyf
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5268-5268
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top